Luigi Mangione Pleads Guilty in UnitedHealthcare CEO Killing Case

Nearly two years after a fatal shooting outside a Manhattan hotel triggered a nationwide manhunt and became one of the country’s most closely watched criminal cases, a major development has changed the legal landscape. Luigi Mangione has formally admitted responsibility in federal court, bringing one prosecution closer to its conclusion while another major legal battle remains ahead.

Mangione pleaded guilty in a Manhattan federal courtroom on 14 August to two federal charges connected to the December 2024 fatal shooting of UnitedHealthcare CEO Brian Thompson. The 28-year-old admitted guilt to two stalking counts resulting in death, reversing his previous not-guilty plea and formally acknowledging his responsibility for the killing before the court.

During the hearing, Mangione directly admitted shooting Thompson and acknowledged that he understood the consequences of his actions. Addressing the judge, he stated: «I shot Mr. Thompson in Manhattan. I understood that my actions would place him in fear of death or bodily injury. I knew what I was doing was illegal.»

Mangione also described steps he took before traveling to New York. He acknowledged researching UnitedHealthcare’s annual investor conference and posing as an investor through email communications to obtain information about the event. That research allowed him to learn details surrounding the conference that Thompson was scheduled to attend in Manhattan in December 2024.

The guilty pleas were entered without a negotiated agreement with federal prosecutors, a procedure commonly known as an open plea. That means Mangione received no guaranteed sentence in exchange for admitting guilt. The two remaining federal stalking counts carry severe potential penalties, and Mangione could ultimately receive life imprisonment without the possibility of parole.

The federal prosecution initially included additional charges that exposed Mangione to the possibility of capital punishment. Earlier in 2026, however, a federal judge dismissed murder and firearms charges that had provided the legal basis for prosecutors to seek the death penalty. The two stalking charges remained and ultimately became the counts to which Mangione pleaded guilty.

The federal plea does not automatically resolve Mangione’s separate prosecution in New York state court. He continues to face second-degree murder and weapons charges related to Thompson’s killing, with his trial scheduled to begin on 8 September. His attorneys are expected to challenge whether that case can legally continue following his federal conviction involving the same underlying events.

Mangione’s defense is expected to argue that New York law prevents him from being prosecuted again for the same underlying course of conduct. Manhattan prosecutors oppose that interpretation, maintaining that the federal stalking offenses and state murder and weapons charges address distinct legal harms. The dispute could become a central issue before the scheduled state trial begins.

Thompson, 50, was shot from behind outside a Midtown Manhattan hotel on 4 December 2024 while heading toward UnitedHealth Group’s annual investor conference. Investigators recovered ammunition casings bearing the words delay, deny and depose, language that quickly intensified public attention surrounding the killing and broader anger directed toward practices within the American health insurance industry.

Mangione escaped New York following the shooting, prompting an intensive multistate search that lasted five days. Authorities eventually arrested him at a McDonald’s restaurant in Altoona, Pennsylvania. Prosecutors say a search of his backpack produced critical evidence, including a 3D-printed pistol matching the type of weapon used in the killing and a handwritten notebook discussing his intentions.

Mangione also described circumstances he said contributed to his actions, pointing to severe chronic pain from a back injury and his resulting frustration with the American healthcare system. His statements provided his own account of a motive investigators had previously examined through writings recovered after his arrest. He now faces federal sentencing while his separate state prosecution remains unresolved.